Korytnikova, E., & Halasz, C. L. (2025). Chronic nonscarring scalp folliculitis responding to topical phosphodiesterase-4 inhibitor roflumilast. JAAD Case Reports, 55, 94–96. https://doi.org/10.1016/j.jdcr.2024.11.009

Rosain, J., Le Voyer, T., Liu, X., Gervais, A., Polivka, L., Cederholm, A., Berteloot, L., Parent, A. V., Pescatore, A., Spinosa, E., Minic, S., Kiszewski, A. E., Tsumura, M., Thibault, C., Esnaola Azcoiti, M., Martinovic, J., Philippot, Q., Khan, T., Marchal, A., … Casanova, J.-L. (2024). Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases. Journal of Experimental Medicine, 221(11). https://doi.org/10.1084/jem.20231152

Neunert, C. E., & Lambert, M. P. (2024). Lightening the load for paediatric ITP: The importance of health‐related quality of life. British Journal of Haematology. Portico. https://doi.org/10.1111/bjh.19719

Adeuyan, O., Trager, M. H., Gordon, E. R., Lapolla, B. A., Schreidah, C. M., Fahmy, L. M., Chen, C., Magro, C. M., & Geskin, L. J. (2024). A unique case of paraneoplastic lymphomatoid Papuloerythroderma of Ofuji with atypical clinical features. JAAD Case Reports, 50, 102–107. https://doi.org/10.1016/j.jdcr.2024.02.009

Gordon, E. R., Adeuyan, O., Kwinta, B. D., Schreidah, C. M., Fahmy, L. M., Queen, D., Trager, M. H., Magro, C. M., & Geskin, L. J. (2024). Exploring cutaneous lymphoproliferative disorders in the wake of COVID‐19 vaccination. Skin Health and Disease, 4(3). Portico. https://doi.org/10.1002/ski2.367

Zhou, J. J., Chen, L. N., Lehan, T., Herzberg, B., Henick, B. S., Pitman, M., Gallitano, S., & Shu, C. A. (2024). Severe scalp ulcerations and granulomata during treatment with amivantamab. Current Problems in Cancer: Case Reports, 13, 100273. https://doi.org/10.1016/j.cpccr.2023.100273

Caux, F., Patsatsi, A., Karakioulaki, M., Antiga, E., Baselga, E., Borradori, L., Caproni, M., Cardones, A. R., Chandran, N. S., Dräger, S., Drenovska, K., Goebeler, M., Günther, C., Hofmann, S. C., Ioannides, D., Joly, P., Marinović, B., Mariotti, E. B., Marzano, A. V., … Schmidt, E. (2024). S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology. Journal of the European Academy of Dermatology and Venereology, 38(6), 1006–1023. Portico. https://doi.org/10.1111/jdv.19880

Blasco, M., & Bomback, A. S. (2024). Complement and Podocytopathies: Do We Have a New Biomarker? Kidney International Reports, 9(3), 520–522. https://doi.org/10.1016/j.ekir.2024.01.037

Kang, J., Park, J., Jo, H., Lee, H., Lee, K., Kim, S., Kang, J., Lee, J. H., Papadopoulos, N. G., Lee, S., Shin, J.-Y., Rahmati, M., Cho, S. H., Cho, J. K., Lee, S., Pizzol, D., Yeo, S. G., Lee, H., Jin, S.-P., & Yon, D. K. (2024). Global Burden of Vaccine-Associated Chronic Urticaria, 2010–2023: From the Global Pharmacovigilance Database. Allergy, Asthma & Immunology Research, 16(6), 613. https://doi.org/10.4168/aair.2024.16.6.613

Rajasekaran, A., Larkina, M., Julian, B. A., Canetta, P. A., Roehm, B. A., Khalid, M., Mariani, L. H., & Rizk, D. V. (2023). Optimal Conservative Therapy Use among Adult Cure Glomerulonephropathy Participants with IgA Nephropathy. Kidney360, 4(12), 1763–1769. https://doi.org/10.34067/kid.0000000000000306

Fahmy, L. M., Schreidah, C. M., Lapolla, B. A., Magro, C. M., & Geskin, L. J. (2023). Mycosis fungoides diagnosed after exposure to risankizumab for psoriasis. JAAD Case Reports, 41, 85–89. https://doi.org/10.1016/j.jdcr.2023.08.049

Sethi, S., Beck, L. H., Glassock, R. J., Haas, M., De Vriese, A. S., Caza, T. N., Hoxha, E., Lambeau, G., Tomas, N. M., Madden, B., Debiec, H., D’Agati, V. D., Alexander, M. P., Amer, H., Appel, G. B., Barbour, S. J., Caravaca-Fontan, F., Cattran, D. C., Casal Moura, M., … Fervenza, F. C. (2023). Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification. Mayo Clinic Proceedings, 98(11), 1671–1684. https://doi.org/10.1016/j.mayocp.2023.08.006

Fahmy, L. M., Schreidah, C. M., Lapolla, B. A., Magro, C. M., & Geskin, L. J. (2023). VEXAS syndrome presenting as refractory cutaneous Kikuchi disease-like inflammatory pattern responding to tofacitinib. JAAD Case Reports, 38, 136–140. https://doi.org/10.1016/j.jdcr.2023.06.021

Youssef, S., & Bordone, L. A. (2023). Oral tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planus. JAAD Case Reports, 37, 16–20. https://doi.org/10.1016/j.jdcr.2023.04.017

Gotlib, J., Castells, M., Elberink, H. O., Siebenhaar, F., Hartmann, K., Broesby-Olsen, S., George, T. I., Panse, J., Alvarez-Twose, I., Radia, D. H., Tashi, T., Bulai Livideanu, C., Sabato, V., Heaney, M., Van Daele, P., Cerquozzi, S., Dybedal, I., Reiter, A., Pongdee, T., … Maurer, M. (2023). Avapritinib versus Placebo in Indolent Systemic Mastocytosis. NEJM Evidence, 2(6). https://doi.org/10.1056/evidoa2200339

Kozlov, M. (2023). Severe Esophageal Lichen Planus Treated With Tofacitinib. Cutis, 111(3). https://doi.org/10.12788/cutis.0717

Batal, I., Khairallah, P., Weins, A., Andeen, N. K., & Stokes, M. B. (2023). The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1124249

Youssef, S., Gallitano, S., & Bordone, L. A. (2023). Two cases of bullous pemphigoid effectively treated with oral tofacitinib. JAAD Case Reports, 32, 77–80. https://doi.org/10.1016/j.jdcr.2022.10.028

Kudose, S., Batal, I., Lucia, J., Patel, P., Soni, R. K., Markowitz, G. S., D’Agati, V. D., & Stokes, M. B. (2023). Proliferative Glomerulonephritis With Hidden Monotypic IgG3κ Deposits: A Case Report. American Journal of Kidney Diseases, 81(1), 114–117. https://doi.org/10.1053/j.ajkd.2022.05.018

Ravipati, P., Freese, R. L., Royal, V., Bu, L., Canetta, P., Gipson, D., Kallash, M., Kiryluk, K., Nast, C., Reich, H. N., Rheault, M. N., Saha, M., & Nachman, P. H. (2022). Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy. Kidney International Reports, 7(11), 2462–2473. https://doi.org/10.1016/j.ekir.2022.08.003

Barratt, J., Tumlin, J., Suzuki, Y., Kao, A., Aydemir, A., Pudota, K., Jin, H., Gühring, H., & Appel, G. (2022). Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria. Kidney International Reports, 7(8), 1831–1841. https://doi.org/10.1016/j.ekir.2022.05.017

Gold, J. A. W., Tolu, S. S., Chiller, T., Benedict, K., & Jackson, B. R. (2021). Incidence of Invasive Fungal Infections in Patients Initiating Ibrutinib and Other Small Molecule Kinase Inhibitors—United States, July 2016–June 2019. Clinical Infectious Diseases, 75(2), 334–337. https://doi.org/10.1093/cid/ciab1026

Kowalski, T., Jiang, N., Lauren, C., Morel, K., Hills, S., Sewell, T., Liao, J., & Mehta, L. (2022). eP161: Homozygous deletion of the terminal exon of DSG3 associated with acantholytic blistering of the oral and laryngeal mucosa. Genetics in Medicine, 24(3), S98–S99. https://doi.org/10.1016/j.gim.2022.01.197

Gotlib, J., Reiter, A., Radia, D. H., Deininger, M. W., George, T. I., Panse, J., Vannucchi, A. M., Platzbecker, U., Alvarez-Twose, I., Mital, A., Hermine, O., Dybedal, I., Hexner, E. O., Hicks, L. K., Span, L., Mesa, R., Bose, P., Pettit, K. M., Heaney, M. L., … DeAngelo, D. J. (2021). Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial. Nature Medicine, 27(12), 2192–2199. https://doi.org/10.1038/s41591-021-01539-8